Hamid Daaboul

Lebanese American University Lebanon

Hamid Elia Daaboul, MD, PhD is an ASCO active member and researcher in the mode of action of new potential anticancer molecules in the Lebanese American University, Lebanon. He is a practicing Oncologist and also a former head of department of Oncology in Haroun Hospital, Lebanon. He earned his PhD in Oncology from Surrey University, London. He studied the mode of action of β-2-himachalen-6-ol, a new anticancer molecule, and succeeded in identifying its apoptotic effect via the inhibition of the mitogen-activated protein kinases (MAPK/ERK) and the phosphatidylinositol 3-kinase (PI3K/AKT) cellular signalling pathways. He is also engaged in clinical trials of other potentially active anticancer molecules.

Hamid Daaboul

1books edited

2chapters authored

Latest work with IntechOpen by Hamid Daaboul

With the support of multinational specialists, each with different background and separate field of expertise in oncology, this book had the occasion to emerge and to offer physicians, researchers and academics efficient, well-organized and updated scientific information related to the characteristics and treatment modalities of squamous cell carcinoma. It provided in-depth information regarding the comprehension of the molecular interaction of signalling pathways and new phenotypes that might result and lead to further cell proliferation and metastases. It also emphasized on the management and individualization of treatment strategies in different types of SCC, applying molecular profiling and approved protocols in order to identify new treatment opportunities. This book also discussed the potential therapeutic modalities that might arise upon understanding and exploring the role of key regulatory proteins that govern the process of cutaneous SCC progression. And Lastly, it underlined the molecular aberrations present in SCC of different organs and the possibility of emerging new therapeutic drugs by targeting these abnormalities. It is really an innovative record that combined novel information from various medical sources and mixed it to become unified in its scientific profit.

Go to the book